| Title | Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. |
| Publication Type | Journal Article |
| Authors | Lannering, B, Rutkowski, S, Doz, F, Pizer, B, Gustafsson, G, Navajas, A, Massimino, M, Reddingius, R, Benesch, M, Carrie, C, Taylor, R, Gandola, L, Björk-Eriksson, T, Giralt, J, Oldenburger, F, Pietsch, T, Figarella-Branger, D, Robson, K, Forni, M, Clifford, C, Warmuth-Metz, M, von Hoff, K, Faldum, A, Mosseri, V, Kortmann, R |
| Full Text | |
| PubMed ID | 22851561 |
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.